-
Track & Monitor
NewInnovation in pharma: transdermal drug delivery
Why settle for outdated information when you can stay ahead of the curve with our comprehensive report? Our team of industry experts has meticulously researched and analyzed the latest trends, innovations, and emerging technologies in the pharma industry’s transdermal drug delivery innovations. By leveraging our report, you'll gain invaluable insights that can revolutionize your business strategies and give you a competitive edge. Why Choose Our Report? Unparalleled Expertise: Our research team consists of seasoned analysts with deep knowledge and experience...
-
Track & Monitor
NewInnovation in Pharmaceuticals: Platinum as active pharmaceutical ingredient
Innovation in the pharmaceuticals industry is relentless, making it hard to stay-on top of the dynamically evolving industry landscape and in early identification of profound shifts, posing high risk of being disrupted if detected too late. GlobalData's coherent data-driven approach, using multiple forward-looking alternative datasets, empowers clients by decoding in advance the disruptive innovations in pharmaceuticals industry. Using patents data, GlobalData's proprietary industry innovation s-curve identifies specific innovation areas and their stage of evolution, i.e., whether they are emerging, accelerating...
-
Thematic Analysis
NewSynthetic Biology – Thematic Intelligence
Synthetic Biology Thematic Report Overview Synthetic biology is commonly abbreviated to synbio. It involves the manipulation of genetic material to enhance specific characteristics or, conversely, stifle them. The ability to perform this manipulation quickly, precisely, and at a low cost has the potential to impact numerous sectors. From developing environmentally friendly luxury materials to novel cancer therapeutics and even the use of DNA as a new form of data storage, the forthcoming field of synbio unlocks several new realms of...
-
Thematic Analysis
NewPharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes in Q3 2023 – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q3 2023 in the Pharma Sector
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ziltivekimab in Systolic Heart Failure
Can Gio Offshore Wind Project is an offshore wind project located in South China Sea, Vietnam. The project is owned and being developed by Asia Petroleum Energy Corp; Shizen Energy Inc; Tokyo Gas Co Ltd. The project is expected to come online in 2036. Empower your strategies with our Can Gio Offshore Wind Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2...
-
Sector Analysis
NewMultiple Myeloma Epidemiology Analysis and Forecast to 2032
Multiple myeloma (MM) (International Statistical Classification of Diseases and Related Health Problems, 10th Revision [ICD-10] code = C90.0 or ICD-O-3 code: 9732/3) is a hematologic cancer that forms in a type of white blood cells called plasma cells. Normal plasma cells help fight infections by making antibodies that recognize and attack germs, but MM causes cancer cells to accumulate in the bone marrow where they crowd out healthy blood cells, impairing their ability to fight infections. Rather than producing helpful...
-
Thematic Analysis
NewInternet of Things (IoT) in Healthcare – Thematic Intelligence
Internet of Things (IoT) in Healthcare Thematic Report Overview Digital transformation has been a steady trend within healthcare for several years. IoT-enabled technologies such as electronic health records, remote patient monitoring, and wearable devices streamline the patient experience and give patients greater agency in their care. The COVID-19 pandemic made the need for IoT more pressing as healthcare providers were forced to enact social distancing policies and cope with staff shortages and patient backlogs while mandated to provide the same...
-
Company Insights
NewMastercard Inc. – Digital transformation strategies
Mastercard Digital Transformation Strategies Report Overview Mastercard uses AI technologies as a part of its digital transformation strategies. The annual ICT spending of Mastercard was estimated at $835 million in 2023. A major share of this spending is earmarked for acquiring software, ICT services, and hardware from vendors. Mastercard Inc (Mastercard) is a payment and technology company, which deals with clearing, authorization, and settlement of payment transactions. It offers a wide range of payment solutions for credit, debit, prepaid, and...
-
Thematic Analysis
NewDigital Transformation and Emerging Technologies in the Healthcare Industry – Thematic Intelligence
Explore trends and insights from the following data in our ‘Digital Transformation and Emerging Technologies in the Healthcare Industry’ report: Stay up to date on the scope, challenges, and essentials for the digital transformation within the healthcare industry. Explore how innovations are transforming the healthcare industry and what impact on the sector these technologies will have soon. Develop and design your corporate strategies through an in-house expert analysis of the key factors of digital transformation and emerging technology in the healthcare sector....
-
Sector Analysis
NewMyasthenia Gravis Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032
The report provides an in-depth assessment of the Myasthenia gravis market including disease overview, epidemiology, current treatment options, unmet needs and opportunities, R&D strategies, pipeline assessment, and market outlook.
-
Product Insights
NewTrigeminal Neuralgia (Tic Douloureux) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Trigeminal Neuralgia (Tic Douloureux) Clinical Trials Overview The Trigeminal Neuralgia (Tic Douloureux) clinical trial report consists of 129 trials. The report provides an overview of the Trigeminal Neuralgia (Tic Douloureux) clinical trials scenario. The report provides top-line data relating to the clinical trials on Trigeminal Neuralgia (Tic Douloureux). It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 &...
-
Product Insights
NewGonorrhea Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Gonorrhea Clinical Trials Overview The Gonorrhea clinical trial report consists of 338 trials. The report provides an overview of the Gonorrhea clinical trials scenario. The report provides top-line data relating to the clinical trials on Gonorrhea. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and sponsor type. The report...
-
Product Insights
NewEwing Sarcoma Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Ewing Sarcoma Clinical Trials Overview The Ewing Sarcoma clinical trial report consists of 430 trials. The report provides an overview of the Ewing Sarcoma clinical trials scenario. The report provides top-line data relating to the clinical trials on Ewing Sarcoma. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and...
-
Product Insights
NewCystic Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Cystic Fibrosis Clinical Trials Overview The Cystic Fibrosis clinical trial report consists of 1285 trials. The report provides an overview of the Cystic Fibrosis clinical trials scenario. The report provides top-line data relating to the clinical trials on Cystic Fibrosis. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and...
-
Product Insights
NewPulmonary Fibrosis Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Pulmonary Fibrosis Clinical Trials Overview The Pulmonary Fibrosis clinical trial report consists of 859 trials. The report provides an overview of the Pulmonary Fibrosis clinical trials scenario. The report provides top-line data relating to the clinical trials on Pulmonary Fibrosis. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and...
-
Product Insights
NewAcute Renal Failure (ARF) (Acute Kidney Injury) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Acute Renal Failure (ARF) (Acute Kidney Injury) Clinical Trials Overview The Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trial report consists of 779 trials. The report provides an overview of the Acute Renal Failure (ARF) (Acute Kidney Injury) clinical trial scenario. The report provides top-line data relating to the clinical trials on Acute Renal Failure (ARF). It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage...
-
Product Insights
NewSpinocerebellar Ataxia (SCA) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Spinocerebellar Ataxia (SCA) Clinical Trials Overview The Spinocerebellar Ataxia (SCA) clinical trial report consists of 77 trials. The report provides an overview of the Spinocerebellar Ataxia (SCA) clinical trial scenario. The report provides top-line data relating to the clinical trials on Spinocerebellar Ataxia (SCA). It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status,...
-
Product Insights
NewAcute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) Clinical Trials Overview The Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trial report consists of 3259 trials. The report provides an overview of the Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) clinical trial scenario. The report provides top-line data relating to the clinical trials on Acute Lymphocytic Leukemia. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of...
-
Product Insights
NewX-Linked Hypophosphatemic Rickets Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
X-Linked Hypophosphatemic Rickets Clinical Trials Overview The X-Linked Hypophosphatemic Rickets clinical trial report consists of 55 trials. The report provides an overview of the X-Linked Hypophosphatemic Rickets clinical trial scenario. The report provides top-line data relating to the clinical trials on X-Linked Hypophosphatemic Rickets. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status,...
-
Product Insights
NewSleep Apnea Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2023 Update
Sleep Apnea Clinical Trials Overview The Sleep Apnea clinical trial report consists of 613 trials. The report provides an overview of the Sleep Apnea clinical trial scenario. The report provides top-line data relating to the clinical trials on Sleep Apnea. It also includes an overview of trial numbers and their average enrolment in top countries conducted across the globe. Moreover, it offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status, and...
Testimonial
Your Drugs database is great, you can find all the information you want such as sales forecasts, countries, diseases, dates, clinical trials, and patent expiration. We are using this information to research the leading competitive products in our current project. In addition, we analyze the profiles of the leading products and use this information to set the differentiation profile of our own products and clarify our positioning. In terms of business forecasts, we are able to provide more objective figures by using the Drug Forecast and Market Analysis report series. The analysis of product share by disease (series of Drug Forecast and Market Analysis reports) is used for business feasibility assessment.”
The ability to evaluate or provide information on PJs in R&D from both product and disease perspectives (it is difficult to find a database that can be used comprehensively for both), stands GlobalData out from other providers. The release of new functions such as Likelihood of approval (LoA) analysis, which was something I wanted but did not exist, shows that GlobalData have done a good job of researching the industry and developing services from the customer’s perspective which is another positive.
GlobalData’s COVID-19 Bulletin, which is sent out several times a week, provides the latest information on COVID-19 related vaccines and therapeutics and is used as background information.
“GlobalData provides extensive and comprehensive Pharma and Biotech data along with spectacular customer support. I use their drug, trial and company data on a daily basis to support our sales and marketing efforts.”
“As a global biopharma R&D strategy consultancy, we use the GlobalData Pharma Intelligence platform across a broad spectrum of topics, it provides all key data in one place”